VBI Vaccines Inc (VBIV) stock has gained 6.90% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With VBIV Stock Today?
VBI Vaccines Inc (VBIV) stock has fallen -2.57% while the S&P 500 is up 0.44% as of 10:53 AM on Wednesday, Dec 23. VBIV is down -$0.09 from the previous closing price of $3.50 on volume of 2,623,241 shares. Over the past year the S&P 500 has gained 14.87% while VBIV is up 184.17%. VBIV lost -$0.21 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for VBI Vaccines Inc click here.
More About VBI Vaccines Inc
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.
Click Here to get the full Stock Score Report on VBI Vaccines Inc (VBIV) Stock.
